同步报告病例3（第七回）：一个家庭护理失败的案例，并“夹生足”的同步治疗经过

字号 + –

15 10月 2019

1
2
3
4
5

Author : 伤口世界

原创：十六点五中山二院糖尿病足中心

经过合作医院差不多20天的治疗

患者再次转入我科

回顾病人这段时间的变化

2018年12月22日

2018年12月24日

足背的溃疡已经完全愈合

足底的溃疡还有一点点

足内侧的3个溃疡面

一个完全愈合

两个明显变浅

下面的照片就是新的一年

2019年

已是他第二次跨年了

希望患者在新的一年中

尽快完全康复

从上面的MRI结果可以看到

其中还是有些空隙

这些空隙是否能够完全愈合

是否能够不重新复发

还需要进一步观察

但我们用了最保险的办法

就是每天老老实实地换药

如果还是不能完全达到目标

也只能仰天长啸：

天不遂人意

673 Views

伤口世界

电子邮件地址该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

Latest from 伤口世界

K2 Content

Diabetes remission in the real world 2024-09-20 00:00

Pam Brown

GP in Swansea

Citation: Brown P (2024) Diabetes Distilled: Diabetes remission in the real world. Diabetes & Primary Care 26: 145–7

Diabetes remission is achievable at scale in the real world, according to early results from the NHS Type 2 Diabetes Path to Remission programme published in Lancet Diabetes & Endocrinology. Of 7540 people referred to the programme between September 2020 and December 2022, a total of 1740 started the total diet replacement section of the programme before January 2022, and 960 (55%) completed the programme. Mean weight loss for the 1710 who started the programme and had follow-up data available was 9.4 kg (8.3%), with a mean weight loss of 10.3 kg (9.3%) among the 945 who completed the programme. Amongst the 945 who completed the programme and had two HbA1c measurements, 32% achieved remission, with mean weight loss of 15.9 kg (14.4%), while overall 27% of those who started the programme achieved remission regardless of whether they completed. Remission rates are lower than in trials such as DiRECT and DIADEM-I, despite similar levels of weight loss. The authors highlight that an additional 17% of participants met the HbA1c targets for remission but continued on metformin and may otherwise have achieved remission. These early results confirm that type 2 diabetes remission is indeed possible at scale in the real world, outside of clinical trials.
Impact of metformin timing on glucose and GLP-1 response 2024-09-19 00:00

Pam Brown GP in Swansea

Citation: Brown P (2024) Diabetes Distilled: Impact of metformin timing on glucose and GLP-1 response. Diabetes & Primary Care 26: 143–4

Glucose-lowering effects in response to normal-release metformin are greater when the drug is given 30 or 60 minutes before, rather than with, food, according to this small study in people with well-controlled type 2 diabetes published in Diabetologia. Endogenous GLP-1 secretion increased when metformin 1000 mg was given 30 or 60 minutes prior to a glucose infusion, whereas there was no increase when the metformin was administered at the same time as the glucose. The results suggest that, if tolerated, administering standard release metformin before meals may lead to improved postprandial glycaemic control.
The importance of getting the correct diabetes diagnosis 2024-09-18 00:00

Jane Diggle Specialist Diabetes Nurse Practitioner, West Yorkshire

Citation: Diggle J (2024) The importance of getting the correct diabetes diagnosis. Diabetes & Primary Care 26: 111–2

Custom Mod Mega1

主任医师、教授、博导，南方医科大学第三附属医院（广东省骨科医院）院长

同步报告病例3（第七回）：一个家庭护理失败的案例，并“夹生足”的同步治疗经过

伤口世界

Latest from 伤口世界

学术会议

伤口世界提示

Custom Mod Mega1

主任医师、教授、博导，南方医科大学第三附属医院（广东省骨科医院）院长

同步报告病例3（第七回）：一个家庭护理失败的案例，并“夹生足”的同步治疗经过

伤口世界

Latest from 伤口世界

消息订阅

学术会议

伤口世界提示